River blindness: An old disease on the brink of elimination and control

Journal of Global Infectious Diseases

Volumn 3, Issue 2, 2011, Pages 151-155

  Winthrop, Kevin L ^a   Furtado, Joao M ^a   Silva, Juan C ^b   Resnikoff, Serge ^c,d   Lansingh, Van C ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (Colombia)

^c International Council of Ophthalmology   (Switzerland)

^d Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS   (Argentina)

Author keywords

Doxycycline; Ivermectin; Onchocerca volvulus; Onchocerciasis; River blindness; Wolbachia

Indexed keywords

DIETHYLCARBAMAZINE; DOXYCYCLINE; IVERMECTIN;

ANTERIOR EYE SEGMENT; ARTICLE; CHORIORETINITIS; CORNEA; DIAGNOSTIC TEST; DISEASE TRANSMISSION; ENDEMIC DISEASE; ERADICATION THERAPY; HUMAN; INFECTION CONTROL; INFECTION RISK; INSECT BITE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATCH TEST; PATHOGENESIS; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; PUBLIC HEALTH; PUNCTATE KERATITIS; SEROLOGY; SIMULIIDAE; SINGLE DRUG DOSE; SKIN BIOPSY; SKIN SNIP; TREATMENT DURATION; WOLBACHIA;

EID: 79959201930     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.81692     Document Type: Article

References (55)

1. Boatin BA, Richards FO Jr. Control of onchocerciasis. Adv Parasitol 2006;61:349-94. (Pubitemid 43792518)
2. Report from the 2009 Inter-American conference on onchocerciasis: Progress towards eliminating river blindness in the Region of the Americas. Wkly Epidemiol Rec 2010;85:321-6.
3. African programme for onchocerciasis control - Report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec 2010;85:23-8.
4. Onchocerciasis (river blindness). Report from the sixteenth InterAmerican conference on onchocerciasis, Antigua Guatemala, Guatemala. Wkly Epidemiol Rec 2007;82:314-6.
5. Zimmerman PA, Katholi CR, Wooten MC, Lang-Unnasch N, Unnasch TR. Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol Biol Evol 1994;11:384-92. (Pubitemid 24137153)
6. Basáñez MG, Pion SD, Churcher TS, Breitling LP, Little MP, Boussinesq M. River blindness: A success story under threat? PLoS Med 2006;3:e371.
7. Cupp EW, Ochoa JO, Collins RC, Cupp MS, Gonzales-Peralta C, Castro J, et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 1992;47:170-80.
8. Pearlman E. Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): A novel role for endosymbiotic Wolbachia bacteria. Med Microbiol Immunol 2003;192:57-60. (Pubitemid 36337708)
9. Saint André A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, Volkmann L, et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002;295:1892-5. (Pubitemid 34214126)
10. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 2000;355:1242-3. (Pubitemid 30184538)
11. Hise AG, Daehnel K, Gillette-Ferguson I, Cho E, McGarry HF, Taylor MJ, et al. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol 2007;178:1068-76. (Pubitemid 46095180)
12. Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Büttner DW, Ceciliani F, et al. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol 2004;173:437-45. (Pubitemid 38797370)
13. Silva JC, Beltran F, Semba R. Evaluacion oftalmológica de la onchocercosis en las Americas. Guatemala: Organizacion panamericana de la Salud and river blindness foundation: 1-14.(published in 1992)
14. Semba RD, Murphy RP, Newland HS, Awadzi K, Greene BM, Taylor HR. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology 1990;97:1334-41. (Pubitemid 20353978)
15. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008;102:19-22.
16. Winthrop KL, Pilkington EF, Dance D, Sauerbrey M, Richards FO. River blindness: Old disease, new challenges. Ophthalmol Int 2008:53-6.
17. Braun G, McKechnie NM, Connor V, Gilbert CE, Engelbrecht F, Whitworth JA, et al. Immunological crossreactivity between a cloned antigen of Onchocerca volvulus and a component of the retinal pigment epithelium. J Exp Med 1991;174:169-77.
18. McKechnie NM, Braun G, Connor V, Kläger S, Taylor DW, Alexander RA, et al. Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis. Invest Ophthalmol Vis Sci 1993;34:2888-902. (Pubitemid 23269143)
19. Braun G, McKechnie NM, Gürr W. Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus. J Exp Med 1995;182:1121-31.
20. Chippaux JP, Boussinesq M, Fobi G, Lafleur C, Audugé A, Banos MT, et al. Effect of repeated ivermectin treatments on ocular onchocerciasis: Evaluation after six to eight doses. Ophthalmic Epidemiol 1999;6:229-46.
21. Winthrop KL, Proaño R, Oliva O, Arana B, Mendoza C, Dominguez A, et al. The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala. Am J Trop Med Hyg 2006;75:1058-62. (Pubitemid 351627480)
22. Taylor HR, Munoz B, Keyvan-Larijani E, Greene BM. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med Hyg 1989;41:467-71. (Pubitemid 19259239)
23. Newell ED. Comparison of the use of skin scarification and skin biopsies to determine the prevalence and intensity of Onchocerca volvulus infection. Ann Trop Med Parasitol 1997;91:633-42. (Pubitemid 27434598)
24. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: First evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009;3:e497.
25. Ozoh G, Boussinesq M, Bissek AC, Kobangue L, Kombila M, Mbina JR, et al. Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Health 2007;12:123-9. (Pubitemid 44973862)
26. Lavebratt C, Dalhammar G, Adamafio NA, Nykänen-Dejerud U, Mingarini K, Ingemarsson K, et al. A simple dot blot assay adaptable for field use in the diagnosis of onchocerciasis: Preparation of an adult worm antigen fraction which enhances sensitivity and specificity. Trans R Soc Trop Med Hyg 1994;88:303-6. (Pubitemid 24206449)
27. Chandrashekar R, Ogunrinade AF, Weil GJ. Use of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis. Trop Med Int Health 1996;1:575-80. (Pubitemid 26356694)
28. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis 2006;194:216-21. (Pubitemid 44087193)
29. Weil GJ, Steel C, Liftis F, Li BW, Mearns G, Lobos E, et al. A rapidformat antibody card test for diagnosis of onchocerciasis. J Infect Dis 2000;182:1796-9.
30. Ayong LS, Tume CB, Wembe FE, Simo G, Asonganyi T, Lando G, et al. Development and evaluation of an antigen detection dipstick assay for the diagnosis of human onchocerciasis. Trop Med Int Health 2005;10:228-33. (Pubitemid 40388969)
31. Kita K, Shiomi K, Omura S. Advances in drug discovery and biochemical studies. Trends Parasitol 2007;23:223-9.
32. Richard-Lenoble D, Chandenier J, Gaxotte P. Ivermectin and filariasis. Fundam Clin Pharmacol 2003;17:199-203. (Pubitemid 36513211)
33. Cupp EW, Bernardo MJ, Kiszewski AE, Collins RC, Taylor HR, Aziz MA, et al. The effects of ivermectin on transmission of Onchocerca volvulus. Science 1986;231:740-2. (Pubitemid 16104049)
34. Tagboto SK, Townson S. Onchocerca volvulus and O. lienalis: The microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo. Ann Trop Med Parasitol 1996;90:497-505. (Pubitemid 26345678)
35. Cotreau MM, Warren S, Ryan JL, Fleckenstein L, Vanapalli SR, Brown KR, et al. The antiparasitic moxidectin: Safety, tolerability, and pharmacokinetics in humans. J Clin Pharmacol 2003;43:1108-15. (Pubitemid 37174442)
36. Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 2001;357:1415-6. (Pubitemid 32455374)
37. Hoerauf A, Specht S, Büttner M, Pfarr K, Mand S, Fimmers R, et al. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: A randomized placebo-controlled study. Med Microbiol Immunol 2008;197:295-311.
38. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, et al. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2009;2:39.
39. Alleman MM, Twun-Danso NA, Thylefors BI. The Mectizan Donation Program-highlights from 2005. Filaria Journal 2006 5:11.
40. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, Richards FO Jr, et al. Ivermectin: Reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg 1992;47:156-69.
41. Dadzie Y, Neira M, Hopkins D. Final report of the Conference on the eradicability of Onchocerciasis. Filaria J 2003;2:2.
42. Sékétéli A. APOC at mid-point: So far so good. Ann Trop Med Parasitol 2002;96:S3-4. (Pubitemid 34297729)
43. Furtado JM, Winthrop KL, Richards Jr FO. River Blindness: Reducing the risk in at-risk populations. Expert Rev Ophthalmol 2011;6:33-41.
44. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: A two-phase epidemiological study. Lancet 2007;369:2021-9. (Pubitemid 46899181)
45. Cupp E, Richards F, Lammie P, Eberhard M. Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 2007;370:1123-5.
46. Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, et al. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: A randomized controlled trial. PLoS Negl Trop Dis 2010;4:e660.
47. Hoerauf A, Specht S, Marfo-Debrekyei Y, Büttner M, Debrah AY, Mand S, et al. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res 2009;104:437-47.
48. Specht S, Hoerauf A, Adjei O, Debrah A, Büttner DW. Newly acquired Onchocerca volvulus filariae after doxycycline treatment. Parasitol Res 2009;106:23-31.
49. Specht S, Mand S, Marfo-Debrekyei Y, Debrah AY, Konadu P, Adjei O, et al. Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus. Parasitol Res 2008;103:1303-9.
50. Richards FO Jr, Miri ES, Katabarwa M, Eyamba A, Sauerbrey M, Zea-Flores G, et al. The Carter Center's assistance to river blindness control programs: Establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents. Am J Trop Med Hyg 2001;65:108-14. (Pubitemid 32744214)
51. Richards FO Jr, Amann J, Arana B, Punkosdy G, Klein R, Blanco C, et al. No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin. Am J Trop Med Hyg 2007;77:878-82. (Pubitemid 351837834)
52. Hoerauf A, Marfo-Debrekyei Y, Büttner M, Debrah AY, Konadu P, Mand S, et al. Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus. Parasitol Res 2008;103:279-86.
53. Debrah AY, Mand S, Marfo-Debrekyei Y, Larbi J, Adjei O, Hoerauf A. Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Filaria J 2006;5:1.
54. Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y, Taylor M, et al. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 2003;5:261-73. (Pubitemid 36428715)
55. Available from http://www.paho.org/english/gov/cd/cd48-10-e.pdf, [Last cited on 2010 Dec 28].